1,782,815 Shares in Humana Inc. $HUM Purchased by Norges Bank

Norges Bank purchased a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, HoldingsChannel reports. The fund purchased 1,782,815 shares of the insurance provider’s stock, valued at approximately $456,632,000.

A number of other hedge funds have also bought and sold shares of the business. Revolve Wealth Partners LLC bought a new position in Humana in the 4th quarter valued at about $202,000. Woodline Partners LP increased its holdings in Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after buying an additional 8,372 shares during the period. Sivia Capital Partners LLC increased its holdings in Humana by 53.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after buying an additional 452 shares during the period. Cresset Asset Management LLC increased its holdings in Humana by 10.3% in the 2nd quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after buying an additional 222 shares during the period. Finally, WINTON GROUP Ltd increased its holdings in Humana by 58.5% in the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after buying an additional 879 shares during the period. 92.38% of the stock is owned by institutional investors.

Humana Trading Up 7.5%

HUM opened at $328.19 on Tuesday. The company’s 50 day moving average is $235.19 and its 200-day moving average is $229.58. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $333.31. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The company has a market cap of $39.40 billion, a P/E ratio of 35.10, a PEG ratio of 2.21 and a beta of 0.68.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same period last year, the company posted $11.58 EPS. The firm’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Equities research analysts predict that Humana Inc. will post 9.01 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.1%. Humana’s dividend payout ratio (DPR) is currently 37.86%.

Analyst Ratings Changes

Several equities analysts have commented on HUM shares. Barclays raised their target price on shares of Humana from $180.00 to $344.00 and gave the company an “equal weight” rating in a report on Tuesday, May 26th. Jefferies Financial Group raised shares of Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. Wolfe Research lowered shares of Humana from a “strong-buy” rating to a “peer perform” rating in a report on Wednesday, May 20th. Finally, Wells Fargo & Company lowered shares of Humana from a “cautious” rating to a “reduce” rating in a report on Wednesday, May 20th. Nine equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $272.65.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.